MML Investors Services
DXCM icon

MML Investors Services’s DexCom DXCM Stock Holding History

MML Investors Services’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3M Sell
153,349
-7,131
-4% -$475K 0.02% 622
2026
Q1 		$10.1M Buy
160,480
+4,299
+3% +$299K 0.03% 542
2025
Q4 		$10.4M Buy
156,181
+123,986
+385% +$8.02M 0.03% 568
2025
Q3 		$2.17M Sell
32,195
-3,729
-10% -$295K 0.01% 1285
2025
Q2 		$3.14M Sell
35,924
-1,283
-3% -$101K 0.01% 1020
2025
Q1 		$2.54M Buy
37,207
+972
+3% +$79.3K 0.01% 1048
2024
Q4 		$2.82M Buy
36,235
+5,260
+17% +$389K 0.01% 956
2024
Q3 		$2.08M Sell
30,975
-34,502
-53% -$2.83M 0.01% 1075
2024
Q2 		$7.42M Sell
65,477
-2,225
-3% -$281K 0.03% 502
2024
Q1 		$9.39M Buy
67,702
+9,217
+16% +$1.16M 0.04% 434
2023
Q4 		$7.26M Buy
58,485
+1,673
+3% +$171K 0.03% 472
2023
Q3 		$5.3M Sell
56,812
-2,916
-5% -$329K 0.03% 517
2023
Q2 		$7.68M Buy
59,728
+5,971
+11% +$722K 0.04% 400
2023
Q1 		$6.25M Sell
53,757
-7,632
-12% -$854K 0.04% 396
2022
Q4 		$6.95M Buy
61,389
+2,455
+4% +$270K 0.05% 392
2022
Q3 		$4.75M Sell
58,934
-427
-0.7% -$36.2K 0.04% 449
2022
Q2 		$4.42M Sell
59,361
-3,943
-6% -$360K 0.03% 465
2022
Q1 		$8.1M Buy
63,304
+4,320
+7% +$473K 0.06% 322
2021
Q4 		$7.92M Buy
58,984
+2,992
+5% +$430K 0.06% 319
2021
Q3 		$7.66M Buy
55,992
+272
+0.5% +$34.3K 0.06% 313
2021
Q2 		$5.95M Buy
55,720
+12,996
+30% +$1.25M 0.05% 356
2021
Q1 		$3.84M Buy
42,724
+9,884
+30% +$928K 0.04% 428
2020
Q4 		$3.04M Buy
32,840
+6,716
+26% +$600K 0.03% 447
2020
Q3 		$2.69M Buy
26,124
+5,888
+29% +$615K 0.03% 425
2020
Q2 		$2.05M Buy
20,236
+7,656
+61% +$685K 0.03% 491
2020
Q1 		$847K Buy
12,580
+2,480
+25% +$154K 0.01% 666
2019
Q4 		$552K Buy
10,100
+2,024
+25% +$96K 0.01% 970
2019
Q3 		$301K Buy
+8,076
New +$314K ﹤0.01% 1181
2019
Q1 		– Sell
-12,028
Closed -$360K – 1598
2018
Q4 		$360K Buy
+12,028
New +$382K 0.01% 1078

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.84B AUM 22.63% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

MML Investors Services's DXCM Position: Q2 2026 in Review

MML Investors Services reduced its DexCom (DXCM) stake by 4.4% in Q2 2026, selling an estimated $475K and leaving 153,349 shares worth $10.3M. The position accounts for 0.02% of the portfolio, ranked #622.

MML Investors Services first reported a position in DXCM in Q4 2018 and has held it in 29 quarters since. The position peaked at $10.4M in Q4 2025. 496 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • MML Investors Services held 153,349 shares of DexCom worth $10.3M as of Q2 2026.
  • MML Investors Services sold 7,131 DexCom shares in Q2 2026, an estimated $475K.
  • DexCom made up 0.02% of MML Investors Services's portfolio in Q2 2026, its #622 holding.
  • MML Investors Services first reported a position in DexCom in Q4 2018 and has held it in 29 quarters since.
  • MML Investors Services's DexCom position peaked at $10.4M in Q4 2025.
  • 496 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.